Ed Silverman
Senior Writer at STAT
Columnist at Pharmalot Newsletter
Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps
Articles
-
2 days ago |
statnews.com | Ed Silverman
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite rising temperatures and hazy skies looming over the Pharmalot campus. After all, the birds are still chirping and a cool breeze is wafting by. Moreover, our official mascots are snoozing somewhere on the premises. We can hear the heavy breathing. As for us, we are brewing more cups of stimulation — butter pecan is the choice today, for those keeping track — and we invite you to join us.
-
3 days ago |
statnews.com | Ed Silverman
In a boost for Merck, a U.S. Patent and Trademark Office panel agreed to reconsider a patent granted to another company that could affect plans to broaden use of its franchise product, the Keytruda cancer treatment. The dispute with Halozyme Therapeutics occurs as Merck plans to sell a new injectable version of Keytruda that the company is betting will sustain a medicine that has accounted for nearly half of its sales.
-
3 days ago |
statnews.com | Ed Silverman
Rise and shine, another busy day is on the way. We can tell because the official mascots got an early start chasing down cats, squirrels, and other creatures darting about the Pharmalot campus. And then there is the noisy parade of school buses, construction trucks, and other assorted vehicles passing nearby on their way to who knows what? As for us, we are firing up the trusty coffee kettle to brew another cup of stimulation. Our choice today is coconut rum. Please feel free to join us.
-
4 days ago |
statnews.com | Ed Silverman
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is banana split, which is fast becoming a trusty favorite. Sounds appetizing, yes? As always, we invite you to join us.
-
5 days ago |
statnews.com | Ed Silverman
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. So this means one thing: time to dig in to the tasks at hand. On that note, we have assembled a menu of tidbits to help you get started. Meanwhile, we have also fired up the coffee kettle for another cup of stimulation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 282
- DMs Open
- No
FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus.. https://t.co/1yetrqOj68… #pharma #FDA #botox #wrinkles #Instagram
Student group that ranked med schools over industry conflicts votes to accept pharma funding.. https://t.co/Oy0tDXJaYA #pharma #medicine #MedicalEducation #medschool #conflicts
““The whole purpose of biosimilars was to introduce competition into the marketplace," said study author Ben Rome. "...The fact that it’s so hard to find savings consistently is disappointing." https://t.co/2VZjM2l1NL #pharma #biotech #biologics #biosimilars #medicines